Journal articleMol Cancer Ther2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer.
- Journal
- Mol Cancer Ther
- Published
- 13 August 2021
- Citations
- 23
- License
- cc by-nc-nd
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try